Fabien Garçon

1.8k total citations
21 papers, 821 citations indexed

About

Fabien Garçon is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Fabien Garçon has authored 21 papers receiving a total of 821 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 10 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Fabien Garçon's work include Immune Cell Function and Interaction (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and T-cell and B-cell Immunology (5 papers). Fabien Garçon is often cited by papers focused on Immune Cell Function and Interaction (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and T-cell and B-cell Immunology (5 papers). Fabien Garçon collaborates with scholars based in United Kingdom, France and United States. Fabien Garçon's co-authors include Klaus Okkenhaug, Daniel T. Patton, Bart Vanhaesebroeck, Antonio Bilancio, Wendy C. Rowan, Faruk Ramadani, Daniel J. Bolland, Anne E. Corcoran, Jacques A. Nunès and Takehiko Sasaki and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Fabien Garçon

20 papers receiving 815 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fabien Garçon United Kingdom 13 540 395 227 186 62 21 821
Catherine Gaudin France 18 549 1.0× 364 0.9× 353 1.6× 72 0.4× 45 0.7× 32 941
Matthew H. Cato United States 13 553 1.0× 321 0.8× 118 0.5× 118 0.6× 47 0.8× 13 822
Antonella Vallario Italy 12 389 0.7× 369 0.9× 290 1.3× 295 1.6× 101 1.6× 17 857
Nadja Zaborsky Austria 18 386 0.7× 283 0.7× 336 1.5× 256 1.4× 102 1.6× 49 945
Evelina Martinenaite Denmark 17 450 0.8× 176 0.4× 338 1.5× 109 0.6× 74 1.2× 33 734
Sarah Ogilvy Australia 9 410 0.8× 510 1.3× 169 0.7× 96 0.5× 219 3.5× 11 910
Matthew D. Blunt United Kingdom 14 281 0.5× 260 0.7× 151 0.7× 179 1.0× 75 1.2× 31 606
Petranel T. Ferrão Australia 6 203 0.4× 336 0.9× 206 0.9× 101 0.5× 151 2.4× 8 629
Piona Dariavach France 14 771 1.4× 306 0.8× 158 0.7× 69 0.4× 45 0.7× 17 1.1k
David J. Rawlings United States 6 669 1.2× 351 0.9× 198 0.9× 230 1.2× 80 1.3× 11 1.0k

Countries citing papers authored by Fabien Garçon

Since Specialization
Citations

This map shows the geographic impact of Fabien Garçon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabien Garçon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabien Garçon more than expected).

Fields of papers citing papers by Fabien Garçon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fabien Garçon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabien Garçon. The network helps show where Fabien Garçon may publish in the future.

Co-authorship network of co-authors of Fabien Garçon

This figure shows the co-authorship network connecting the top 25 collaborators of Fabien Garçon. A scholar is included among the top collaborators of Fabien Garçon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabien Garçon. Fabien Garçon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Natoli, Marina, Fabien Garçon, Rodrigo Aguilera Olvera, et al.. (2024). 1073 AZD5863, a CLDN18.2 and CD3 binding T-cell engager, establishes a multi-faceted antitumour immune response and combines effectively with chemo-immunotherapy regimens. Regular and Young Investigator Award Abstracts. A1194–A1194. 1 indexed citations
2.
Candido, Juliana, Gozde Kar, Fabien Garçon, et al.. (2023). 785 mAZD0171 mediated LIF blockade in combination with chemotherapy and PD-L1 inhibition repolarizes macrophages and increases T cell infiltration via CX3CR1-CX3CL1 axis. SHILAP Revista de lepidopterología. A882–A882. 1 indexed citations
3.
Johansen, K., Dominic P. Golec, Bonnie Huang, et al.. (2022). A CRISPR screen targeting PI3K effectors identifies RASA3 as a negative regulator of LFA-1–mediated adhesion in T cells. Science Signaling. 15(743). eabl9169–eabl9169. 15 indexed citations
4.
Eyles, Jim, Amanda Watkins, Kristina M. Ilieva, et al.. (2021). Abstract 1584: Efficacy and pharmacodynamic effect of anti-CD73/PD-L1 monoclonal antibodies in combination with chemotherapy: Observations from mouse tumor models. Cancer Research. 81(13_Supplement). 1584–1584.
5.
Lau, Doreen, Fabien Garçon, Anita Chandra, et al.. (2020). Intravital Imaging of Adoptive T-Cell Morphology, Mobility and Trafficking Following Immune Checkpoint Inhibition in a Mouse Melanoma Model. Frontiers in Immunology. 11. 1514–1514. 29 indexed citations
6.
Luheshi, Nadia, Susannah L. Hewitt, Fabien Garçon, et al.. (2019). Abstract 5017: MEDI1191, a novel IL-12 mRNA therapy for intratumoral injection to promote TH1 transformation of the patient tumor microenvironment. Cancer Research. 79(13_Supplement). 5017–5017. 7 indexed citations
7.
Luheshi, Nadia, Susannah L. Hewitt, Fabien Garçon, et al.. (2019). Abstract 5017: MEDI1191, a novel IL-12 mRNA therapy for intratumoral injection to promote TH1 transformation of the patient tumor microenvironment. Immunology. 5017–5017. 1 indexed citations
8.
Benson, Robert A., Fabien Garçon, John R. Ferdinand, et al.. (2018). Non-Invasive Multiphoton Imaging of Islets Transplanted Into the Pinna of the NOD Mouse Ear Reveals the Immediate Effect of Anti-CD3 Treatment in Autoimmune Diabetes. Frontiers in Immunology. 9. 1006–1006. 9 indexed citations
9.
Garçon, Fabien & Klaus Okkenhaug. (2016). PI3Kδ promotes CD4+ T‐cell interactions with antigen‐presenting cells by increasing LFA‐1 binding to ICAM‐1. Immunology and Cell Biology. 94(5). 486–495. 17 indexed citations
10.
Soond, Dalya R., Fabien Garçon, Daniel T. Patton, et al.. (2012). Pten Loss in CD4 T Cells Enhances Their Helper Function but Does Not Lead to Autoimmunity or Lymphoma. The Journal of Immunology. 188(12). 5935–5943. 31 indexed citations
11.
Ramadani, Faruk, Daniel J. Bolland, Fabien Garçon, et al.. (2010). The PI3K Isoforms p110α and p110δ Are Essential for Pre–B Cell Receptor Signaling and B Cell Development. Science Signaling. 3(134). ra60–ra60. 158 indexed citations
12.
Saudemont, Aurore, Fabien Garçon, Marta Roche-Molina, et al.. (2009). p110γ and p110δ isoforms of phosphoinositide 3-kinase differentially regulate natural killer cell migration in health and disease. Proceedings of the National Academy of Sciences. 106(14). 5795–5800. 66 indexed citations
13.
Garçon, Fabien & Jacques A. Nunès. (2007). Travel Informations on the TEC Kinases during Lymphocyte Activation. Advances in experimental medicine and biology. 584. 15–27. 1 indexed citations
14.
Patton, Daniel T., Fabien Garçon, & Klaus Okkenhaug. (2007). The PI3K p110δ controls T-cell development, differentiation and regulation. Biochemical Society Transactions. 35(2). 167–171. 22 indexed citations
15.
Garçon, Fabien, Daniel T. Patton, Emilio Hirsch, et al.. (2007). CD28 provides T-cell costimulation and enhances PI3K activity at the immune synapse independently of its capacity to interact with the p85/p110 heterodimer. Blood. 111(3). 1464–1471. 126 indexed citations
16.
Okkenhaug, Klaus, Daniel T. Patton, Antonio Bilancio, et al.. (2006). The p110δ Isoform of Phosphoinositide 3-Kinase Controls Clonal Expansion and Differentiation of Th Cells. The Journal of Immunology. 177(8). 5122–5128. 168 indexed citations
17.
Garçon, Fabien, Georges Bismuth, Daniel Isnardon, Daniel Olive, & Jacques A. Nunès. (2004). Tec Kinase Migrates to the T Cell-APC Interface Independently of Its Pleckstrin Homology Domain. The Journal of Immunology. 173(2). 770–775. 12 indexed citations
18.
Hagenbeek, Thijs J., Marianne Naspetti, Fabrice Malergue, et al.. (2004). The Loss of PTEN Allows TCR αβ Lineage Thymocytes to Bypass IL-7 and Pre-TCR–mediated Signaling. The Journal of Experimental Medicine. 200(7). 883–894. 103 indexed citations
19.
Garçon, Fabien, Marguerite Ghiotto, Audrey Gérard, et al.. (2004). The SH3 domain of Tec kinase is essential for its targeting to activated CD28 costimulatory molecule. European Journal of Immunology. 34(7). 1972–1980. 20 indexed citations
20.
Gérard, Audrey, Cédric Favre, Fabien Garçon, et al.. (2003). Functional interaction of RasGAP-binding proteins Dok-1 and Dok-2 with the Tec protein tyrosine kinase. Oncogene. 23(8). 1594–1598. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026